{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:17:05Z","timestamp":1771636625035,"version":"3.50.1"},"reference-count":167,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013301","name":"Parkinson\u2019s Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100013301","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurologic Clinics"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ncl.2019.12.003","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T10:54:45Z","timestamp":1581504885000},"page":"269-292","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Treatment of Nonmotor Symptoms Associated with Parkinson Disease"],"prefix":"10.1016","volume":"38","author":[{"given":"Jennifer G.","family":"Goldman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos Manuel","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ncl.2019.12.003_bib1","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.003_bib2","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/WCO.0000000000000112","article-title":"Premotor and nonmotor features of Parkinson's disease","volume":"27","author":"Goldman","year":"2014","journal-title":"Curr Opin Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.003_bib4","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/mds.27431","article-title":"Movement disorder society criteria for clinically established early Parkinson's disease","volume":"33","author":"Berg","year":"2018","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib5","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11910-017-0738-x","article-title":"Subtypes of Parkinson's disease: what do they tell us about disease progression?","volume":"17","author":"Fereshtehnejad","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.ncl.2019.12.003_bib6","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/bs.irn.2017.05.020","article-title":"Biomarkers of nonmotor symptoms in Parkinson's disease","volume":"133","author":"Konno","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.003_bib7","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1002\/mds.26510","article-title":"Nonmotor features of Parkinson's disease subtypes","volume":"31","author":"Marras","year":"2016","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.irn.2017.05.018","article-title":"Nonmotor symptoms in experimental models of Parkinson's disease","volume":"133","author":"Titova","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.003_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/14737175.2019.1561285","article-title":"Multidisciplinary care for people with Parkinson's disease: the new kids on the block!","volume":"19","author":"Radder","year":"2019","journal-title":"Expert Rev Neurother"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.003_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.003_bib11","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/mds.26643","article-title":"Prevalence of anxiety in Parkinson's disease: a systematic review and meta-analysis","volume":"31","author":"Broen","year":"2016","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib12","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1212\/WNL.0000000000002898","article-title":"Detecting depression in Parkinson disease: a systematic review and meta-analysis","volume":"87","author":"Goodarzi","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.12.003_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/mds.10010","article-title":"Factors impacting on quality of life in Parkinson\u2019s disease: results from an international survey","volume":"17","year":"2002","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S1041610219000048","article-title":"Improved understanding, detection, and management of neuropsychiatric complications: essential components to the optimal treatment of Parkinson's disease","volume":"31","author":"Dobkin","year":"2019","journal-title":"Int Psychogeriatr"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.003_bib15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.parkreldis.2015.03.024","article-title":"Neuropsychiatric symptoms and caregiver's burden in Parkinson's disease","volume":"21","author":"Martinez-Martin","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/bs.irn.2017.05.024","article-title":"Depression and anxiety in Parkinson's disease","volume":"133","author":"Schrag","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.ncl.2019.12.003_bib17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.parkreldis.2016.09.029","article-title":"Association between common genetic risk variants and depression in Parkinson's disease: a dPD study in Chinese","volume":"33","author":"Dan","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/bs.irn.2017.05.029","article-title":"Genes and nonmotor symptoms in Parkinson's disease","volume":"133","author":"Lim","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.ncl.2019.12.003_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpsychires.2017.02.010","article-title":"Neuroimaging of major depression in Parkinson's disease: cortical thickness, cortical and subcortical volume, and spectroscopy findings","volume":"90","author":"Chagas","year":"2017","journal-title":"J\u00a0Psychiatr Res"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.003_bib20","doi-asserted-by":"crossref","first-page":"e0211699","DOI":"10.1371\/journal.pone.0211699","article-title":"Effectiveness of imaging genetics analysis to explain degree of depression in Parkinson's disease","volume":"14","author":"Won","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.ncl.2019.12.003_bib21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.parkreldis.2018.04.020","article-title":"Emergence of non-motor fluctuations with reference to motor fluctuations in Parkinson's disease","volume":"54","author":"Kim","year":"2018","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clineuro.2014.10.006","article-title":"Non-motor fluctuations in Parkinson's disease: prevalence, characteristics and management in a large cohort of parkinsonian outpatients","volume":"127","author":"Brun","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.003_bib23","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/mds.24041","article-title":"Parkinson's disease motor subtypes and mood","volume":"27","author":"Burn","year":"2012","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.003_bib24","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1136\/jnnp.2010.213652","article-title":"Depression and anxiety related subtypes in Parkinson's disease","volume":"82","author":"Brown","year":"2011","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.003_bib25","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.parkreldis.2015.04.018","article-title":"Antidepressive treatments for Parkinson's disease: a systematic review and meta-analysis","volume":"21","author":"Bomasang-Layno","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"22","key":"10.1016\/j.ncl.2019.12.003_bib26","doi-asserted-by":"crossref","first-page":"e6698","DOI":"10.1097\/MD.0000000000006698","article-title":"Efficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysis","volume":"96","author":"Zhuo","year":"2017","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.003_bib27","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1212\/01.wnl.0000336340.89821.b3","article-title":"A\u00a0controlled trial of antidepressants in patients with Parkinson disease and depression","volume":"72","author":"Menza","year":"2009","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.003_bib28","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","article-title":"Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Barone","year":"2010","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.003_bib29","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.parkreldis.2013.02.018","article-title":"Rotigotine and specific non-motor symptoms of Parkinson's disease: post hoc analysis of RECOVER","volume":"19","author":"Chaudhuri","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib30","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.jns.2017.02.020","article-title":"Impact of STN-DBS on mood, drive, anhedonia and risk of psychiatric side-effects in the population of PD patients","volume":"375","author":"Antosik-Wojcinska","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2019.12.003_bib31","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jns.2019.05.009","article-title":"Lack of independent mood-enhancing effect for dopaminergic medications in early Parkinson's disease","volume":"402","author":"Espay","year":"2019","journal-title":"J\u00a0Neurol Sci"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.003_bib32","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1080\/14656566.2019.1612877","article-title":"Drug treatment strategies for depression in Parkinson disease","volume":"20","author":"Ryan","year":"2019","journal-title":"Expert Opin Pharmacother"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib33","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.neuropharm.2011.08.039","article-title":"Anxiety in Parkinson's disease: a critical review of experimental and clinical studies","volume":"62","author":"Prediger","year":"2012","journal-title":"Neuropharmacology"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.003_bib34","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jagp.2016.08.017","article-title":"Neuropsychiatric complications of Parkinson disease treatments: importance of multidisciplinary care","volume":"24","author":"Taylor","year":"2016","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.ncl.2019.12.003_bib35","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2147\/NDT.S152221","article-title":"Cognitive behavioral group therapy versus psychoeducational intervention in Parkinson's disease","volume":"14","author":"Berardelli","year":"2018","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.003_bib36","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/gps.5077","article-title":"Cognitive behavioral therapy improves diverse profiles of depressive symptoms in Parkinson's disease","volume":"34","author":"Dobkin","year":"2019","journal-title":"Int J Geriatr Psychiatry"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.003_bib37","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/07317115.2016.1240131","article-title":"Cognitive behavior therapy for anxiety in Parkinson's disease: outcomes for patients and caregivers","volume":"40","author":"Dissanayaka","year":"2017","journal-title":"Clin Gerontol"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.003_bib38","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1017\/S1041610218000340","article-title":"Remote delivery of psychological interventions for Parkinson's disease","volume":"30","author":"Swalwell","year":"2018","journal-title":"Int Psychogeriatr"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib39","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1080\/07317115.2019.1580811","article-title":"Telephone-delivered cognitive behavioural therapy for treating symptoms of anxiety and depression in Parkinson's disease: a pilot trial","volume":"42","author":"Wuthrich","year":"2019","journal-title":"Clin Gerontol"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.003_bib40","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00702-019-02019-7","article-title":"Neuropsychiatric aspects of Parkinson's disease","volume":"126","author":"Nagy","year":"2019","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.003_bib41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/mds.25874","article-title":"The tools of the trade: a state of the art \"how to assess cognition\" in the patient with Parkinson's disease","volume":"29","author":"Marras","year":"2014","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib42","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1002\/mds.27330","article-title":"Initial cognitive changes in Parkinson's disease","volume":"33","author":"Weintraub","year":"2018","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib43","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jns.2017.01.012","article-title":"Dementia in Parkinson's disease","volume":"374","author":"Hanagasi","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib44","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/13548506.2018.1510131","article-title":"Caregiver burden and family functioning in different neurological diseases","volume":"24","author":"Tramonti","year":"2019","journal-title":"Psychol Health Med"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.003_bib45","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1002\/mds.27135","article-title":"Cognitive changes in prodromal Parkinson's disease: a review","volume":"32","author":"Fengler","year":"2017","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.003_bib46","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/jnnp-2013-305277","article-title":"The CamPaIGN study of Parkinson's disease: 10-year outlook in an incident population-based cohort","volume":"84","author":"Williams-Gray","year":"2013","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.003_bib47","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/mds.27233","article-title":"Global scales for cognitive screening in Parkinson's disease: critique and recommendations","volume":"33","author":"Skorvanek","year":"2018","journal-title":"Mov Disord"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.003_bib48","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mds.25873","article-title":"Psychiatric issues in cognitive impairment","volume":"29","author":"Aarsland","year":"2014","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib49","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/mds.27323","article-title":"Evolution of diagnostic criteria and assessments for Parkinson's disease mild cognitive impairment","volume":"33","author":"Goldman","year":"2018","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.003_bib50","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: movement disorder society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov Disord"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.003_bib51","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00702-019-02003-1","article-title":"Mild cognitive impairment in Parkinson's disease","volume":"126","author":"Martinez-Horta","year":"2019","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.003_bib52","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson's disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov Disord"},{"issue":"14","key":"10.1016\/j.ncl.2019.12.003_bib53","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1212\/WNL.0000000000000842","article-title":"Predictors of dementia in Parkinson disease: a prospective cohort study","volume":"83","author":"Anang","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib54","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/mds.26312","article-title":"Gray and white matter imaging: a biomarker for cognitive impairment in early Parkinson's disease?","volume":"31","author":"Duncan","year":"2016","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1148\/radiol.12111280","article-title":"Interregional correlations in Parkinson disease and Parkinson-related dementia with resting functional MR imaging","volume":"263","author":"Seibert","year":"2012","journal-title":"Radiology"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib56","doi-asserted-by":"crossref","DOI":"10.1111\/ene.13258","article-title":"Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature","volume":"24","author":"Fagan","year":"2017","journal-title":"Eur J Neurol"},{"issue":"Pt 6","key":"10.1016\/j.ncl.2019.12.003_bib57","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/brain\/awv104","article-title":"Parkinson's disease dementia: a neural networks perspective","volume":"138","author":"Gratwicke","year":"2015","journal-title":"Brain"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.003_bib58","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/mds.26291","article-title":"Exercise improves cognition in Parkinson's disease: the PRET-PD randomized, clinical trial","volume":"30","author":"David","year":"2015","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bandc.2017.01.002","article-title":"Improved cognition while cycling in Parkinson's disease patients and healthy adults","volume":"113","author":"Hazamy","year":"2017","journal-title":"Brain Cogn"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.003_bib60","first-page":"541","article-title":"Impact of neuropsychiatric symptoms on the quality of life of subjects with Parkinson's disease","volume":"5","author":"Alvarado-Bolanos","year":"2015","journal-title":"J\u00a0Parkinsons Dis"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.003_bib61","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/mds.22839","article-title":"The changing face of Parkinson's disease-associated psychosis: a cross-sectional study based on the new NINDS-NIMH criteria","volume":"25","author":"Fenelon","year":"2010","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.003_bib62","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1001\/archneurol.2010.166","article-title":"A\u00a012-year population-based study of psychosis in Parkinson disease","volume":"67","author":"Forsaa","year":"2010","journal-title":"Arch Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib63","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/mds.26432","article-title":"Minor hallucinations occur in drug-naive Parkinson's disease patients, even from the premotor phase","volume":"31","author":"Pagonabarraga","year":"2016","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib64","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/mds.21875","article-title":"Scales to assess psychosis in Parkinson's disease: critique and recommendations","volume":"23","author":"Fernandez","year":"2008","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.003_bib65","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.parkreldis.2012.10.022","article-title":"Performance of a shortened scale for assessment of positive symptoms for Parkinson's disease psychosis","volume":"19","author":"Voss","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.003_bib66","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/jnnp.2008.153163","article-title":"Impact of standard of care for psychosis in Parkinson disease","volume":"79","author":"Thomsen","year":"2008","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.003_bib67","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S1474-4422(15)00019-8","article-title":"Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment","volume":"14","author":"Pagonabarraga","year":"2015","journal-title":"Lancet Neurol"},{"issue":"14","key":"10.1016\/j.ncl.2019.12.003_bib68","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1002\/mds.23268","article-title":"Neuroanatomical correlates of apathy in Parkinson's disease: a magnetic resonance imaging study using voxel-based morphometry","volume":"25","author":"Reijnders","year":"2010","journal-title":"Mov Disord"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.003_bib69","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1176\/jnp.4.2.134","article-title":"Reliability, validity, and clinical correlates of apathy in Parkinson's disease","volume":"4","author":"Starkstein","year":"1992","journal-title":"J\u00a0Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.ncl.2019.12.003_bib70","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","article-title":"Impulse control and related disorders in Parkinson's disease","volume":"133","author":"Weintraub","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.003_bib71","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1212\/WNL.0b013e31827b915c","article-title":"Screening for impulse control symptoms in patients with de novo Parkinson disease: a case-control study","volume":"80","author":"Weintraub","year":"2013","journal-title":"Neurology"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.003_bib72","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1002\/mds.27181","article-title":"Impulse control disorders in advanced Parkinson's disease with dyskinesia: the ALTHEA study","volume":"32","author":"Biundo","year":"2017","journal-title":"Mov Disord"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.003_bib73","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1212\/WNL.0000000000005816","article-title":"Longitudinal analysis of impulse control disorders in Parkinson disease","volume":"91","author":"Corvol","year":"2018","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.003_bib74","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","article-title":"Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study","volume":"85","author":"Garcia-Ruiz","year":"2014","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.003_bib75","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1002\/ana.22356","article-title":"Impulse control disorders in Parkinson disease: a multicenter case--control study","volume":"69","author":"Voon","year":"2011","journal-title":"Ann Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.003_bib76","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1002\/mds.27047","article-title":"Mesocorticolimbic hemodynamic response in Parkinson's disease patients with compulsive behaviors","volume":"32","author":"Claassen","year":"2017","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/mds.21770","article-title":"Long-term follow-up of impulse control disorders in Parkinson's disease","volume":"23","author":"Mamikonyan","year":"2008","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jns.2016.12.070","article-title":"Dopamine agonist withdrawal syndrome: a comprehensive review","volume":"374","author":"Yu","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2019.12.003_bib79","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jns.2017.01.019","article-title":"Management of impulse control disorders with deep brain stimulation: a double-edged sword","volume":"374","author":"Kasemsuk","year":"2017","journal-title":"J\u00a0Neurol Sci"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.003_bib80","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11910-018-0838-2","article-title":"Disturbances of sleep and alertness in Parkinson's disease","volume":"18","author":"Videnovic","year":"2018","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.003_bib81","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1136\/jnnp-2017-316136","article-title":"Impact of sleep-related symptoms on clinical motor subtypes and disability in Parkinson's disease: a multicentre cross-sectional study","volume":"88","author":"Suzuki","year":"2017","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib82","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1468-1331.2007.01998.x","article-title":"The frequency and nature of sleep disorders in a community-based population of patients with Parkinson's disease","volume":"15","author":"Porter","year":"2008","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.003_bib83","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1093\/sleep\/25.2.120","article-title":"REM sleep behavior disorder: clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP","volume":"25","author":"Schenck","year":"2002","journal-title":"Sleep"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib84","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","article-title":"Idiopathic REM sleep behaviour disorder and neurodegeneration - an update","volume":"14","author":"Hogl","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib85","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s12883-017-0795-4","article-title":"Meta-analysis on the prevalence of REM sleep behavior disorder symptoms in Parkinson's disease","volume":"17","author":"Zhang","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/j.ncl.2019.12.003_bib86","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.parkreldis.2019.01.018","article-title":"Clinical progression in Parkinson's disease with features of REM sleep behavior disorder: a population-based longitudinal study","volume":"62","author":"Duarte Folle","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.003_bib87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.5664\/jcsm.2670","article-title":"Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample","volume":"9","author":"Boeve","year":"2013","journal-title":"J\u00a0Clin Sleep Med"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.003_bib88","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/mds.25438","article-title":"Questionnaire-based diagnosis of REM sleep behavior disorder in Parkinson's disease","volume":"28","author":"Chahine","year":"2013","journal-title":"Mov Disord"},{"issue":"16","key":"10.1016\/j.ncl.2019.12.003_bib89","doi-asserted-by":"crossref","first-page":"2386","DOI":"10.1002\/mds.21740","article-title":"The REM sleep behavior disorder screening questionnaire--a new diagnostic instrument","volume":"22","author":"Stiasny-Kolster","year":"2007","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib90","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/mds.24909","article-title":"Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease","volume":"27","author":"Di Giacopo","year":"2012","journal-title":"Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib91","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/0891988719856687","article-title":"Chronic insomnia in patients with Parkinson disease: which associated factors are relevant?","volume":"33","author":"Sobreira-Neto","year":"2019","journal-title":"J\u00a0Geriatr Psychiatry Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.003_bib92","first-page":"577","article-title":"A\u00a0pilot study on a specific measure for sleep disorders in Parkinson's disease: SCOPA-sleep","volume":"43","author":"Martinez-Martin","year":"2006","journal-title":"Rev Neurol"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib93","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/mds.23476","article-title":"Parkinson's disease sleep scale\u2014validation of the revised version PDSS-2","volume":"26","author":"Trenkwalder","year":"2011","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib94","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41531-017-0027-z","article-title":"Cognitive behavioral therapy for insomnia in Parkinson's disease: a case series","volume":"3","author":"Humbert","year":"2017","journal-title":"NPJ Parkinsons Dis"},{"key":"10.1016\/j.ncl.2019.12.003_bib95","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.sleep.2016.01.016","article-title":"Rotigotine may improve sleep architecture in Parkinson's disease: a double-blind, randomized, placebo-controlled polysomnographic study","volume":"21","author":"Pierantozzi","year":"2016","journal-title":"Sleep Med"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib96","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1442-2018.2012.00711.x","article-title":"Effect of cognitive behavior therapy on sleep disorder in Parkinson's disease in China: a pilot study","volume":"14","author":"Yang","year":"2012","journal-title":"Nurs Health Sci"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.003_bib97","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/j.sleep.2015.05.028","article-title":"Natural course of restless legs syndrome\/Willis-Ekbom disease: long-term observation of a large clinical cohort","volume":"16","author":"Mitterling","year":"2015","journal-title":"Sleep Med"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.003_bib98","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11910-019-0965-4","article-title":"Update on restless legs syndrome: from mechanisms to treatment","volume":"19","author":"Gonzalez-Latapi","year":"2019","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.003_bib99","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2165\/11539720-000000000-00000","article-title":"Excessive daytime sleepiness in patients with Parkinson's disease","volume":"25","author":"Knie","year":"2011","journal-title":"CNS Drugs"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.003_bib100","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1212\/WNL.0000000000001737","article-title":"Development of excessive daytime sleepiness in early Parkinson disease","volume":"85","author":"Tholfsen","year":"2015","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.ncl.2019.12.003_bib101","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","article-title":"Excessive daytime sleepiness and subsequent development of Parkinson disease","volume":"65","author":"Abbott","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.ncl.2019.12.003_bib102","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fneur.2019.00121","article-title":"Clinical features and correlates of excessive daytime sleepiness in Parkinson's disease","volume":"10","author":"Xiang","year":"2019","journal-title":"Front Neurol"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.003_bib103","doi-asserted-by":"crossref","first-page":"e81233","DOI":"10.1371\/journal.pone.0081233","article-title":"Objective measurement of daytime napping, cognitive dysfunction and subjective sleepiness in Parkinson's disease","volume":"8","author":"Bolitho","year":"2013","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib104","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamaneurol.2016.5192","article-title":"Timed light therapy for sleep and daytime sleepiness associated with Parkinson disease: a randomized clinical trial","volume":"74","author":"Videnovic","year":"2017","journal-title":"JAMA Neurol"},{"issue":"17","key":"10.1016\/j.ncl.2019.12.003_bib105","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1212\/WNL.0000000000004568","article-title":"Caffeine as symptomatic treatment for Parkinson disease (Cafe-PD): a randomized trial","volume":"89","author":"Postuma","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.003_bib106","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","article-title":"Sleep and circadian rhythm regulation in early Parkinson disease","volume":"71","author":"Breen","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ncl.2019.12.003_bib107","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2019.02.041","article-title":"Slave to the rhythm: seasonal differences in non-motor symptoms in Parkinson's disease","volume":"63","author":"van Wamelen","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.003_bib108","doi-asserted-by":"crossref","first-page":"e12673","DOI":"10.1111\/jsr.12673","article-title":"An overview of sleep and circadian dysfunction in Parkinson's disease","volume":"27","author":"Mantovani","year":"2018","journal-title":"J\u00a0Sleep Res"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.003_bib109","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00702-019-02039-3","article-title":"Sleep-wake and circadian disturbances in Parkinson disease: a short clinical guide","volume":"126","author":"Baumann","year":"2019","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s12264-016-0089-7","article-title":"A\u00a0new perspective for Parkinson's disease: circadian rhythm","volume":"33","author":"Li","year":"2017","journal-title":"Neurosci Bull"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.003_bib111","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1001\/jamaneurol.2017.1125","article-title":"Association of autonomic dysfunction with disease progression and survival in Parkinson disease","volume":"74","author":"De Pablo-Fernandez","year":"2017","journal-title":"JAMA Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.003_bib112","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1212\/WNL.0000000000004274","article-title":"Loss of cutaneous large and small fibers in naive and l-dopa-treated PD patients","volume":"89","author":"Nolano","year":"2017","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.003_bib113","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/mds.25445","article-title":"Prodromal autonomic symptoms and signs in Parkinson's disease and dementia with Lewy bodies","volume":"28","author":"Postuma","year":"2013","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib114","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.parkreldis.2019.07.008","article-title":"Longitudinal assessment of autonomic dysfunction in early Parkinson's disease","volume":"66","author":"Stankovic","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib115","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s10072-012-1176-9","article-title":"Orthostatic hypotension, non-dipping and striatal dopamine in Parkinson disease","volume":"34","author":"Oh","year":"2013","journal-title":"Neurol Sci"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.003_bib116","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000314573","article-title":"Importance of 123I-metaiodobenzylguanidine scintigraphy\/single photon emission computed tomography for diagnosis and differential diagnostics of Parkinson syndromes","volume":"7","author":"Jost","year":"2010","journal-title":"Neurodegener Dis"},{"key":"10.1016\/j.ncl.2019.12.003_bib117","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jns.2016.09.036","article-title":"Cardiovascular dysfunction in untreated Parkinson's disease: a multi-modality assessment","volume":"370","author":"Strano","year":"2016","journal-title":"J\u00a0Neurol Sci"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.003_bib118","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1007\/s00702-016-1594-6","article-title":"Predictors of postprandial hypotension in elderly patients with de novo Parkinson's disease","volume":"123","author":"Umehara","year":"2016","journal-title":"J\u00a0Neural Transm (Vienna)"},{"issue":"9","key":"10.1016\/j.ncl.2019.12.003_bib119","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S1474-4422(16)30079-5","article-title":"Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets","volume":"15","author":"Espay","year":"2016","journal-title":"Lancet Neurol"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.003_bib120","first-page":"1567","article-title":"The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension and associated supine hypertension","volume":"264","author":"Gibbons","year":"2017","journal-title":"J\u00a0Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.003_bib121","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.jash.2016.07.009","article-title":"Effects of the novel norepinephrine prodrug, droxidopa, on ambulatory blood pressure in patients with neurogenic orthostatic hypotension","volume":"10","author":"Kaufmann","year":"2016","journal-title":"J\u00a0Am Soc Hypertens"},{"issue":"1\u20132","key":"10.1016\/j.ncl.2019.12.003_bib122","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jns.2011.06.047","article-title":"Mechanisms of orthostatic hypotension and supine hypertension in Parkinson disease","volume":"310","author":"Sharabi","year":"2011","journal-title":"J\u00a0Neurol Sci"},{"key":"10.1016\/j.ncl.2019.12.003_bib123","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.parkreldis.2016.10.024","article-title":"Lower urinary tract symptoms in Parkinson's disease: prevalence, aetiology and management","volume":"35","author":"McDonald","year":"2017","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.003_bib124","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.parkreldis.2015.02.025","article-title":"Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson's disease","volume":"21","author":"Zesiewicz","year":"2015","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.003_bib125","first-page":"960","article-title":"Botulinum toxin type A in patients with Parkinson's disease and refractory overactive bladder","volume":"186","author":"Giannantoni","year":"2011","journal-title":"J\u00a0Urol"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.003_bib126","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/ner.12446","article-title":"The impact of pallidal and subthalamic deep brain stimulation on urologic function in Parkinson's disease","volume":"19","author":"Mock","year":"2016","journal-title":"Neuromodulation"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib127","first-page":"7","article-title":"The frequency and severity of gastrointestinal symptoms in patients with early Parkinson's disease","volume":"7","author":"Sung","year":"2014","journal-title":"J\u00a0Mov Disord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib128","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neulet.2005.11.012","article-title":"Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology","volume":"396","author":"Braak","year":"2006","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib129","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/mds.27105","article-title":"The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder","volume":"33","author":"Heintz-Buschart","year":"2018","journal-title":"Mov Disord"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib130","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/WNF.0000000000000037","article-title":"Pharmacokinetics of levodopa in patients with Parkinson disease and motor fluctuations depending on the presence of Helicobacter pylori infection","volume":"37","author":"Narozanska","year":"2014","journal-title":"Clin Neuropharmacol"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.003_bib131","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/S1474-4422(15)00007-1","article-title":"Gastrointestinal dysfunction in Parkinson's disease","volume":"14","author":"Fasano","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ncl.2019.12.003_bib132","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/bs.irn.2017.04.011","article-title":"Weight in Parkinson's disease: phenotypical significance","volume":"134","author":"Sharma","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.003_bib133","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s10072-016-2708-5","article-title":"Pathophysiology underlying drooling in Parkinson's disease: oropharyngeal bradykinesia","volume":"37","author":"Karakoc","year":"2016","journal-title":"Neurol Sci"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib134","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.parkreldis.2011.11.006","article-title":"Prevalence of oropharyngeal dysphagia in Parkinson's disease: a meta-analysis","volume":"18","author":"Kalf","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib135","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00455-015-9671-9","article-title":"Dysphagia in Parkinson's disease","volume":"31","author":"Suttrup","year":"2016","journal-title":"Dysphagia"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib136","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1002\/mds.26866","article-title":"Constipation in Parkinson's disease: subjective symptoms, objective markers, and new perspectives","volume":"32","author":"Knudsen","year":"2017","journal-title":"Mov Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib137","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.parkreldis.2016.05.016","article-title":"Constipation and risk of Parkinson's disease: a Danish population-based cohort study","volume":"28","author":"Svensson","year":"2016","journal-title":"Parkinsonism Relat Disord"},{"issue":"21","key":"10.1016\/j.ncl.2019.12.003_bib138","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182574f28","article-title":"Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease","volume":"78","author":"Ondo","year":"2012","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.003_bib139","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/jgs.13279","article-title":"Nizatidine ameliorates slow transit constipation in Parkinson's disease","volume":"63","author":"Sakakibara","year":"2015","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"5","key":"10.1016\/j.ncl.2019.12.003_bib140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.parkreldis.2012.01.001","article-title":"Apomorphine injections: predictors of initial common adverse events and long term tolerability","volume":"18","author":"Ondo","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib141","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.parkreldis.2019.04.014","article-title":"Barriers to reporting non-motor symptoms to health-care providers in people with Parkinson's","volume":"64","author":"Hurt","year":"2019","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib142","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jns.2016.07.058","article-title":"Abnormal sexuality in Parkinson's disease: fact or fancy?","volume":"369","author":"Ferrucci","year":"2016","journal-title":"J\u00a0Neurol Sci"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.003_bib143","first-page":"2433","article-title":"Sexual dysfunction is associated with postural instability gait difficulty subtype of Parkinson's disease","volume":"262","author":"Deng","year":"2015","journal-title":"J\u00a0Neurol"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.003_bib144","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1111\/ene.13983","article-title":"The PRIAMO study: active sexual life is associated with better motor and non-motor outcomes in men with early Parkinson's disease","volume":"26","author":"Picillo","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.ncl.2019.12.003_bib145","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/B978-0-444-63247-0.00017-1","article-title":"Sexuality in patients with Parkinson's disease, Alzheimer's disease, and other dementias","volume":"130","author":"Bronner","year":"2015","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib146","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/brain\/awy298","article-title":"Wait and you shall see: sexual delay discounting in hypersexual Parkinson's disease","volume":"142","author":"Girard","year":"2019","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib147","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/mdc3.12561","article-title":"The role of sex therapy in the management of patients with Parkinson's disease","volume":"5","author":"Bronner","year":"2018","journal-title":"Mov Disord Clin Pract"},{"issue":"8","key":"10.1016\/j.ncl.2019.12.003_bib148","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jnr.23729","article-title":"Sensory symptoms in Parkinson's disease: clinical features, pathophysiology, and treatment","volume":"94","author":"Zhu","year":"2016","journal-title":"J\u00a0Neurosci Res"},{"issue":"4","key":"10.1016\/j.ncl.2019.12.003_bib149","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/mds.24054","article-title":"Prevalence of pain in Parkinson's disease: a systematic review using the modified QUADAS tool","volume":"27","author":"Broen","year":"2012","journal-title":"Mov Disord"},{"issue":"11","key":"10.1016\/j.ncl.2019.12.003_bib150","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1093\/brain\/aww175","article-title":"Visual dysfunction in Parkinson's disease","volume":"139","author":"Weil","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.ncl.2019.12.003_bib151","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/bs.irn.2017.04.007","article-title":"Visual dysfunction in Parkinson's disease","volume":"134","author":"Armstrong","year":"2017","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.ncl.2019.12.003_bib152","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/2047-783X-19-29","article-title":"Stereopsis impairment is associated with decreased color perception and worse motor performance in Parkinson's disease","volume":"19","author":"Sun","year":"2014","journal-title":"Eur J Med Res"},{"issue":"6","key":"10.1016\/j.ncl.2019.12.003_bib153","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1037\/neu0000276","article-title":"Impaired perception of biological motion in Parkinson's disease","volume":"30","author":"Jaywant","year":"2016","journal-title":"Neuropsychology"},{"issue":"10","key":"10.1016\/j.ncl.2019.12.003_bib154","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1080\/00207454.2016.1275617","article-title":"Physical therapy and occupational therapy in Parkinson's disease","volume":"127","author":"Radder","year":"2017","journal-title":"Int J Neurosci"},{"issue":"2","key":"10.1016\/j.ncl.2019.12.003_bib155","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1444-0938.2007.00211.x","article-title":"Visual signs and symptoms of Parkinson's disease","volume":"91","author":"Armstrong","year":"2008","journal-title":"Clin Exp Optom"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib156","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/2045-709X-20-31","article-title":"What is the prevalence of musculoskeletal problems in the elderly population in developed countries? A systematic critical literature review","volume":"20","author":"Fejer","year":"2012","journal-title":"Chiropr Man Therap"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.003_bib157","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.parkreldis.2013.03.002","article-title":"Musculoskeletal problems in Parkinson's disease: neglected issues","volume":"19","author":"Kim","year":"2013","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.003_bib158","first-page":"133","article-title":"Musculoskeletal problems affect the quality of life of patients with Parkinson's disease","volume":"11","author":"Kim","year":"2018","journal-title":"J\u00a0Mov Disord"},{"key":"10.1016\/j.ncl.2019.12.003_bib159","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.clineuro.2017.12.011","article-title":"Predictive risk factors for chronic low back pain in Parkinson's disease","volume":"164","author":"Ozturk","year":"2018","journal-title":"Clin Neurol Neurosurg"},{"issue":"Pt B","key":"10.1016\/j.ncl.2019.12.003_bib160","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.pnpbp.2017.10.010","article-title":"Chronic pain and pain processing in Parkinson's disease","volume":"87","author":"Blanchet","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"15","key":"10.1016\/j.ncl.2019.12.003_bib161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14656566.2019.1639672","article-title":"The challenge of pain in the pharmacological management of Parkinson's disease","volume":"20","author":"Jost","year":"2019","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.ncl.2019.12.003_bib162","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/bs.irn.2017.05.034","article-title":"Osteoporosis: a hidden nonmotor face of Parkinson's disease","volume":"134","author":"Metta","year":"2017","journal-title":"Int Rev Neurobiol"},{"issue":"12","key":"10.1016\/j.ncl.2019.12.003_bib163","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1016\/j.clinph.2014.03.024","article-title":"Forehead sympathetic skin responses in determining autonomic involvement in Parkinson's disease","volume":"125","author":"Sariahmetoglu","year":"2014","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.ncl.2019.12.003_bib164","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-5945-14-5","article-title":"A\u00a0laboratory-based study on patients with Parkinson's disease and seborrheic dermatitis: the presence and density of Malassezia yeasts, their different species and enzymes production","volume":"14","author":"Arsic Arsenijevic","year":"2014","journal-title":"BMC Dermatol"},{"issue":"7","key":"10.1016\/j.ncl.2019.12.003_bib165","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.mayocp.2017.03.014","article-title":"Parkinson disease and melanoma: confirming and reexamining an association","volume":"92","author":"Dalvin","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"10.1016\/j.ncl.2019.12.003_bib166","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13760-019-01195-3","article-title":"Levodopa-induced skin disorders in patients with Parkinson disease: a systematic literature review approach","volume":"119","author":"Bougea","year":"2019","journal-title":"Acta Neurol Belg"},{"issue":"1","key":"10.1016\/j.ncl.2019.12.003_bib167","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/mdc3.12425","article-title":"The skin and Parkinson's disease: review of clinical, diagnostic, and therapeutic issues","volume":"4","author":"Skorvanek","year":"2017","journal-title":"Mov Disord Clin Pract"}],"container-title":["Neurologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861919301136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733861919301136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T10:17:41Z","timestamp":1760005061000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733861919301136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":167,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0733861919301136"],"URL":"https:\/\/doi.org\/10.1016\/j.ncl.2019.12.003","relation":{},"ISSN":["0733-8619"],"issn-type":[{"value":"0733-8619","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of Nonmotor Symptoms Associated with Parkinson Disease","name":"articletitle","label":"Article Title"},{"value":"Neurologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncl.2019.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}